Neuro-Degenerative Disease: Clinical Trials

56 trials for Neuro-Degenerative Disease, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

22 completed, 11 unknown, 10 recruiting, 5 active not recruiting. 17 Not applicable, 7 Phase 1, 6 Phase 2, 2 Early Phase 1, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable17Completed 9, Unknown 4, Recruiting 3, Active not recruiting 1
Phase 17Completed 2, Not yet recruiting 2, Terminated 1, Unknown 1, Withdrawn 1
Phase 26Not yet recruiting 2, Active not recruiting 1, Completed 1, Recruiting 1, Unknown 1
Early Phase 12Completed 1, Terminated 1
Phase 41Active not recruiting 1

Follow Neuro-Degenerative Disease: new trials by email Literature Review of Neuro-Degenerative Disease trials Research Report on Neuro-Degenerative Disease

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
C-CAR168, an Autologous Anti-CD20/BCMA Chimeric Antigen Receptor T-Cell Therapy, in Participants With Progressive Multiple Sclerosis Refractory to Standard Therapy
C-CAR168 - Multiple Sclerosis, Primary Progressive Multiple Sclerosis
Phase 1 / Phase 2Not yet recruitingAbelZeta Inc.1192027-02-012026-10-13
Walking and Thinking - Brain Activity During Complex Walking in Stroke
No Interventions - Stroke, Aging
RecruitingKarolinska Institutet502026-08-012026-06-03
3D Printers for Autonomy in the Care of Inpatients in Continuing and Rehabilitation Care
adapted cutlery handle printed with 3D printer - Neuro-Degenerative Disease
Not applicableRecruitingCentre Hospitalier Intercommunal de Toulon La Seyne sur Mer752026-03-302026-07-07
Eccentric Cycling in Multiple Sclerosis Rehabilitation
Eccentric training, Concentric training - Multiple Sclerosis, Rehabilitation
Not applicableActive not recruitingUniversity of Liege602026-03-272026-10-06
Kamlanoflast In Amyotrophic Lateral Sclerosis
Kamlanoflast - ALS (Amyotrophic Lateral Sclerosis), ALS
Phase 1 / Phase 2Not yet recruitingInflammasome Therapeutics402026-02-012026-02-09
Lived Experience Narratives in Dementia
Online LEND Intervention - Dementia, Neuro-Degenerative Disease
Not applicableRecruitingUniversity of Nottingham602025-11-172026-08-11
A Vision-Language Foundation Model for Brain Disease Diagnosis From Multimodal Data
No Interventions - Brain (Nervous System) Cancers, Brain Arterial Disease
RecruitingXiangya Hospital of Central South University1000002025-05-152025-08-17
100-Year Human Aging Study
Comprehensive Multi-System Clinical Screening - Aging, Aging Well
RecruitingLongevity Metrics, Inc.10000002025-02-092026-09-08
Digital Diagnostics and Intervention Services for Parkinson's Disease
Brain Diseases, Central Nervous System Diseases
UnknownUniversity of Exeter802024-10-152024-08-09
Evaluation of the Safety, Tolerability and PK Characteristics of GV1001 in Healthy Subjects
GV1001, Placebo - Neuro-Degenerative Disease
Phase 1CompletedGemVax & Kael592024-10-082025-11-19
A Prospective Natural History and Outcome Measure Discovery Study of Charcot-Marie-Tooth Disease, Type 4J
Peripheral Neuropathy, Neuro-Degenerative Disease
Active not recruitingElpida Therapeutics SPC202024-07-292026-07-08
First-In-Human (FIH), Single Ascending Dose (SAD) Study of FluoroEthylNorMemantine (FENM)
Fluoroethylnormemantine (FENM) - PTSD, Alzheimer Disease
Phase 1WithdrawnReST Therapeutics2024-05-022024-05-03
Conventional Physical Therapy Action Observation Therapy on Freezing of Gait and Functional Mobility in Parkinson's Disease
Conventional Physical Therapy, Action Observation plus conventional Physical Therapy - Parkinson Disease, Neuro-Degenerative Disease
Not applicableCompletedUniversity of Lahore422023-06-012026-06-16
Walking and Thinking - Brain Activity During Complex Walking in People With Multiple Sclerosis
No intervention - Multiple Sclerosis, Gait Disorders, Neurologic
CompletedKarolinska Institutet412023-04-212024-10-24
HIFT Training in People With Parkinson's Disease
Hight intensity functional trainning - Neuro-Degenerative Disease
Not applicableCompletedUniversity of Valencia152023-03-012025-09-09
Randomised Clinical Trial to Evaluate the Efficacy of an Online Cognitive Rehabilitation Programme (COPERIA-COG) for Patients With Persistent COVID-19
Sessions of cognitive stimulation - COVID-19, Neuro-Degenerative Disease
Not applicableUnknownFundacin Biomedica Galicia Sur882022-12-142022-12-02
Cross Cultural Validation of the Italian Version of the Clinical Assessment of Dysphagia in Neurodegeneration
Administration of Clinical Assessment of Dysphagia in Neurodegeneration (CADN) - Swallowing Disorder, Dysphagia
CompletedIstituti Clinici Scientifici Maugeri SpA1012022-04-052026-03-02
Volume Mode Non-invasive Ventilation in Amyotrophic Lateral Sclerosis
iVAPS-AE, ST-mode - Amyotrophic Lateral Sclerosis, Respiratory Failure
Not applicableUnknownUniversity Hospitals Coventry and Warwickshire NHS Trust402022-03-152023-06-01
Visualization of Neural Targets With 3T MRI
MRI - Neuro-Degenerative Disease
UnknownUniversity Health Network, Toronto402022-01-292024-05-08
Efficiency of E-learning and Role-playing for the Training of Nursing Home Caregivers in the Support of Agitation in Neurodegenerative Diseases
I-LEARN training, usual care - Neuro-Degenerative Disease
CompletedUniversity Hospital, Tours1702021-11-082026-11-02

Showing 20 of 56. Sign in to see all of them.

Narrower conditions

Parkinson Disease (12)  ·  Alzheimer Disease (10)  ·  Brain Diseases (7)  ·  Neoplasms (7)  ·  Dementia (6)  ·  Multiple Sclerosis (6)  ·  Movement Disorders (5)  ·  Nervous System Diseases (5)  ·  Stroke (4)  ·  Amyotrophic Lateral Sclerosis (3)  ·  Autoimmune Diseases (3)  ·  Cardiovascular Diseases (3)  ·  Cognitive Dysfunction (3)  ·  Digestive System Diseases (3)  ·  Genetic Diseases, Inborn (3)

Broader conditions

Nervous System Diseases (31)  ·  Central Nervous System Diseases (28)  ·  Brain Diseases (21)  ·  Neurodegenerative Diseases (20)  ·  Mental Disorders (15)  ·  Neurocognitive Disorders (12)  ·  Nutritional and Metabolic Diseases (12)  ·  Basal Ganglia Diseases (11)  ·  Parkinsonian Disorders (11)  ·  Pathological Conditions, Signs and Symptoms (11)  ·  Synucleinopathies (11)  ·  Tauopathies (10)  ·  Metabolic Diseases (8)  ·  Movement Disorders (8)  ·  Behavior (7)

Interventions

Exome (2)  ·  Magnetic Resonance Imaging (2)  ·  Atorvastatin (1)  ·  CNBP protein, human (1)  ·  Clonidine (1)  ·  Dopamine Agonists (1)  ·  Electroencephalography (1)  ·  Frataxin (1)  ·  GV1001 peptide (1)  ·  Lipoproteins, HDL2 (1)  ·  Memantine (1)  ·  Myotonin-Protein Kinase (1)  ·  Nutrition Assessment (1)  ·  Patient Navigation (1)  ·  Phlebotomy (1)

Sponsors

University Health Network, Toronto (3)  ·  Chinese University of Hong Kong (2)  ·  Karolinska Institutet (2)  ·  Weill Medical College of Cornell University (2)  ·  AbelZeta Inc. (1)  ·  Carl Allen (1)  ·  Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer (1)  ·  Clinical Hospital Center Rijeka (1)  ·  Duke University (1)  ·  Ege University (1)  ·  Elpida Therapeutics SPC (1)  ·  Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta (1)  ·  Friedreich's Ataxia Research Alliance (1)  ·  Fundacin Biomedica Galicia Sur (1)  ·  GemVax & Kael (1)

Countries

United States (13)  ·  Canada (7)  ·  Italy (7)  ·  Sweden (4)  ·  Belgium (3)  ·  Australia (2)  ·  Finland (2)  ·  France (2)  ·  Hong Kong (2)  ·  Spain (2)  ·  United Kingdom (2)  ·  China (1)  ·  Croatia (1)  ·  India (1)  ·  Israel (1)

Top investigators

P. David Mozley, MD (2)  ·  Adeline Su-Lyn Ng (1)  ·  Andres Lozano (1)  ·  Andres M Lozano, MD/PhD (1)  ·  Andrew Mackie, MD (1)  ·  Anna Solini, MD, PhD (1)  ·  Barbara Koenig, PhD (1)  ·  Carl E Allen, MD, PhD (1)  ·  Carmela Tartaglia, MD (1)  ·  Cyril Goizet (1)  ·  David G Parr, MD (1)  ·  David Lynch, MD PhD (1)

Results publications

PMID 13211501, PMID 15086662, PMID 16713924, PMID 17270453, PMID 17517356, PMID 18347911, PMID 18927158, PMID 20194584, PMID 20216060, PMID 21403820, PMID 22884182, PMID 22990349, PMID 23320132, PMID 23777359, PMID 24090098, PMID 24158978, PMID 24699052, PMID 24825731, PMID 25104243, PMID 25739555, PMID 26418222, PMID 27916710, PMID 28079169, PMID 28811842, PMID 29936326, PMID 29997519, PMID 30423359, PMID 31130879, PMID 31398354, PMID 31826899, PMID 31921482, PMID 35396980, PMID 35723922, PMID 35817567, PMID 36602886, PMID 37782421, PMID 37920607, PMID 38072889, PMID 38588457, PMID 39382077, PMID 39601514, PMID 39928304, PMID 39939891, PMID 40038366, PMID 40598011, PMID 40632537, PMID 41667276, PMID 41970152, PMID 42757837, PMID 7514502

NIH funding

R01AG069818 (1), R01NR017181 (1), U01HG009599 (1)